Western blot analyses were performed according to widely established protocols. The following antibodies were used: anti-ABL (a-ABL) Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-phosphorylated ABL specific for the phosphorylated tyrosine-residues 245 (a-p-ABL-Y245) (Upstate-Biotechnology, Lake Placid, NY, USA), anti-BCR (a-BCR) (Santa Cruz Biotechnology), anti-phosphorylated BCR-Y177 (a-p-BCR-Y177) (Cell Signaling, Boston, USA), anti-STAT5, anti phosphorylated STAT5 (Cell Signaling, Boston, MA, USA), anti-Erk1/2 and anti phosphorylated Erk1/2 (Cell Signaling, Boston, MA, USA). Blocking and antibody incubation were performed in 5% low-fat dry milk.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.